Filing Details
- Accession Number:
- 0001209191-16-130312
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-30 18:58:56
- Reporting Period:
- 2016-06-28
- Filing Date:
- 2016-06-30
- Accepted Time:
- 2016-06-30 18:58:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591213 | A Paul Foster | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-06-28 | 1,183 | $17.01 | 2,419 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
Billionaire Hedge Funds
